Oncologists Spend Too Little Time With Patients, Too Much on EHR
The Medscape Oncologist Compensation Report 2018 reveals more about oncology practice than simple dollars and cents. (Source: Medscape Oncology)
Source: Medscape Oncology - April 26, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Neoadjuvant Immunotherapy Data Suggest More Lung Cancer Cures
Among the new data on immunotherapy for lung cancer presented at the recent AACR meeting, the potential role of immune checkpoint inhibitors in the neoadjuvant setting may be the most promising. (Source: Medscape Oncology)
Source: Medscape Oncology - April 26, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Checkpoint Inhibitors Have a Role for 'Virtually Every Patient'
After an ' extraordinary week ' of advances in lung cancer, Dr Mark Kris explains why checkpoint inhibitors now play a major role in lung cancer therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - April 25, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'Oncology Done Right Is About Balance': Weighing IO Side Effects
When discussing checkpoint inhibitor adverse effects, Dr Mark Kris argues that we have to consider their potentially outsize benefits. (Source: Medscape Oncology)
Source: Medscape Oncology - April 23, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Stop Screening for Early Ovarian Cancer, USPSTF Says
There is no evidence that screening actually improves outcomes in ovarian cancer, according to a USPSTF analysis of the best available data. (Source: Medscape Oncology)
Source: Medscape Oncology - April 13, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'100,000 Genomes' Project: Linking Genome Sequencing to Outcomes
Dr David Kerr shares thoughts on the 100,000 Genomes project linking whole genome sequencing to outcomes and the skepticism among some colleagues about the benefits of so-called actionable mutations. (Source: Medscape Oncology)
Source: Medscape Oncology - April 10, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
An Alternative to Dalteparin for Cancer-Related VTE
Dr David Kerr discusses a promising new study suggesting that oral edoxaban may be substituted for daily subcutaneous dalteparin in cancer patients who have had a venous thromboembolism. (Source: Medscape Oncology)
Source: Medscape Oncology - April 2, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Is Genotype Screening Needed Before Fluoropyrimidines?
Dr David Kerr on how the recent case for DPYD screening may be on (and off) mark in addressing chemotherapy toxicity. (Source: Medscape Oncology)
Source: Medscape Oncology - March 15, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
A Moment to Reflect on Communicating Bad News to Patients
Dr David J. Kerr discusses the difficult task of delivering bad news to patients--and their often paradoxical response--by sharing one of his favorite poems by Raymond Carver (Source: Medscape Oncology)
Source: Medscape Oncology - March 13, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Combined Prognostic Factors Clarify Colorectal Cancer Risk
Dr David Kerr on how combining ploidy and stroma-tumor fraction can guide treatment decisions in patients with stage II disease. (Source: Medscape Oncology)
Source: Medscape Oncology - March 12, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Survey: Stark Disparities Exist in Global Oncologists' Workload
Dr David Kerr on a first-of-its-kind analysis revealing that much work is needed to alleviate the burden on colleagues worldwide. (Source: Medscape Oncology)
Source: Medscape Oncology - March 9, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'False Hope' Over Immunotherapy? The Media's Misguided Effects
Dr Kathy Miller responds to a recentNew York Timesarticle documenting rare immunotherapy responses, which may lead to false hope among cancer patients and their families. (Source: Medscape Oncology)
Source: Medscape Oncology - March 6, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'Tremendous Loss' of a Giant in Psycho-Oncology
Dr Mark Kris pays tribute to a true giant in the field of oncology and his dear friend, Jimmie Holland. (Source: Medscape Oncology)
Source: Medscape Oncology - March 5, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Is Aspirin the New (Old) Immunotherapy?
Dr David Kerr on how this time-tested drug enhances more complex and expensive immunotherapies. (Source: Medscape Oncology)
Source: Medscape Oncology - March 1, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Lower-Dose Combo Immunotherapy Promising for Advanced Melanoma
Dr Jeffrey S. Weber reviews data from an open-label phase 1/2 trial assessing the efficacy and safety of combination pembrolizumab and reduced-dose ipilimumab in patients with advanced melanoma. (Source: Medscape Oncology)
Source: Medscape Oncology - February 22, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
